Dr Ailawadhi on Iopofosine I-131 in Waldenström Macroglobulinemia
January 5th 2024
Sikander Ailawadhi, MD, oncologist, Department of Hematology, CAR T-Cell Therapy Program, Mayo Clinic, discusses how the investigational agent iopofosine I-131 may address unmet needs for patients with Waldenström macroglobulinemia.